Advertisements


We are Sorry, This Page doesn't Exist


Sarepta"s stock is up 11% on positive data from clinical trial for Duchenne treatment

Shares of Sarepta Therapeutics Inc. gained 11.3% in trading on Tuesday after the co.....»»

Category: topSource: marketwatchMay 18th, 2021

Heat Biologics stock more than doubles after "positive" trial data of its lung cancer treatment

Shares of Heat Biologics Inc. more than doubled in very active trading Tuesday, after the biopharmaceutical company focused on modulating the immune system reported "positive" in.....»»

Category: topSource: marketwatchFeb 9th, 2021

UniQure"s stock rallies 7% on positive safety data for Huntington"s disease treatment

Shares of UniQure gained 7.2% in trading on Monday after the company said an independent data safety monitoring board said there were no safety concerns in a Phase 2/3 clinical trial for its experimental Huntington's disease treatment. The boar.....»»

Category: topSource: marketwatchFeb 8th, 2021

Aclaris Therapeutics stock more than triples after "positive" data on arthritis treatment trial

Shares of Aclaris Therapeutics Inc. skyrocketed more than 200% toward a 2 1/2-year high, on massive volume, in midday trading Tuesday, after the bioph.....»»

Category: topSource: marketwatchJan 19th, 2021

Mallinckrodt"s stock shoots up after positive phase 3 trial data on HRS-1 treatment

Shares of Mallinckrodt PLC shot up 11% in premarket trading Thursday, after .....»»

Category: topSource: marketwatchAug 15th, 2019

Deciphera Pharmaceuticals stock more than doubles on heavy volume after positive trial data

Shares of Deciphera Pharmaceuticals Inc. more than doubled toward a 14-month high in active premarket trading Tuesday, after the biopharmaceutical company said a phase 3 trial of its treatment of gastrointestinal stromal tumo.....»»

Category: topSource: marketwatchAug 13th, 2019

Incyte"s stock plunges, Merck shares fall after disappointing study results of melanoma treatment

Shares of Incyte Corp. plunged 19% in premarket trade Friday, and Merck & Co. Inc.'s stock dropped 1.9%, after the companies said an external data monitoring comm.....»»

Category: topSource: marketwatchApr 6th, 2018

Incyte"s stock set for selloff, Merck shares drop after disappointing study results of melanoma treatment

Incyte Corp. and Merck & Co. Inc. said an external data monitoring committee (eDMC) determined that results from a phas.....»»

Category: topSource: marketwatchApr 6th, 2018

Merck announces positive results for Keytruda in melanoma trial

Merck & Co. Inc. said Monday its Keytruda drug showed positive results in a late-stage trial as a.....»»

Category: topSource: marketwatchJun 4th, 2018

Merck Presents Positive Melanoma Data on Keytruda at ASCO

Merck (MRK) presents encouraging data from two pivotal advanced melanoma studies on its PD-L1 inhibitor, Keytruda. Merck & Co., .....»»

Category: personnelSource: nytJun 5th, 2018

UPDATE: Cara Therapeutics stock surges 34% on news of positive results in trial of post-surgery pain treatment

Cara Therapeutics Inc. shares soared 34% in premarket trade Wednesday, after the company reported positive data in a Phase 2/3 trial of a t.....»»

Category: topSource: marketwatchJun 27th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Galectin"s GR-MD-02 Positive in Phase Ib Study With Keytruda

Galectin Therapeutics (GALT) posts favorable results from a phase Ib study on GR-MD-02 combined with Merck's Keytruda for treating metastatic melanoma. Shares of Galectin Therapeutics, Inc. GALT rallied 14.5% fo.....»»

Category: smallbizSource: nytSep 21st, 2018

Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data

Shares of Ultragenyx Pharmaceutical Inc. rose 2.9% in premarket trade Tuesday after the company announced positive results from a safety and efficacy study looking at a treatment for patients with lo.....»»

Category: topSource: marketwatchJan 22nd, 2019

BioLine RX rockets on heavy volume after "strikingly positive" trial data on cancer treatment

Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»

Category: topSource: marketwatchMay 4th, 2021

Eli Lilly, Vir and Glaxo announce positive data in Phase 2 trial of COVID antibody treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMar 29th, 2021

Aclaris Therapeutics" stock skyrockets 220% on positive data for potential arthritis treatment

More than 113 million shares of the company traded on Tuesday. By comparison, 295,200 shares changed hands on Friday......»»

Category: topSource: bizjournalsJan 19th, 2021

Biogen"s stock is up 5% after Lilly reports positive data from an Alzheimer"s study

Shares of Biogen Inc. gained 5.6% in trading on Monday after another drugmaker shared positive clinical data about an experimental Alzheimer's disease treatment that is similar to a Biogen therapy under review by the Food and Drug A.....»»

Category: topSource: marketwatchJan 11th, 2021

US stock futures rise after solid tech earnings, Facebook up more than 10%

Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»

Category: topSource: moneycentralApr 30th, 2020

US stock futures rise after solid tech earnings

Stocks ended higher Wednesday on the back of positive data from a potential coronavirus treatment from Gilead Sciences, while traders assessed a sharp drop in U.S. economic activity......»»

Category: topSource: moneycentralApr 30th, 2020